Regeneron Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$748.71(as of Dec 18, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Regeneron Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$748.71
Ticker SymbolREGN
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees15,222
CountyUSA
Market Cap$81,394.1M
EBIDTA4,348.0M
10-Day Moving Average737.56
P/E Ratio17.98
20-Day Moving Average745.10
Forward P/E Ratio17.64
50-Day Moving Average677.57
Earnings per Share41.70
200-Day Moving Average599.54
Profit Margin38.89%
RSI64.26
Shares Outstanding103.3M
ATR20.69
52-Week High790.98
Volume2,335,900
52-Week Low475.17
Book Value30,957.8M
P/B Ratio2.66
Upper Keltner791.65
P/S Ratio5.78
Lower Keltner698.55
Debt-to-Equity Ratio791.65
Next Earnings Date01/30/2026
Cash Surplus-1,918.7M
Next Ex-Dividend DateUnknown
Looking for a prescription for success? Then this could be the stock for you. Regeneron is at the forefront of biotechnology that develops and commercializes life-transforming medicines. They are best known for their blockbuster drug Eylea, which is used to treat age-related macular degeneration—a leading cause of blindness in the elderly.
Regeneron Pharmaceuticals Inc In Our Stock Scanner
As of Dec 19, 2025
Scan Name: Uptrending StocksScan Type: Chart Pattern Scans
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.